This inventor holds 1 USPTO granted patent. Top assignees: Perseus Proteomics Inc., The University of Tokyo. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 27 
1 out of 1,356 
Years Active: 2011
Title: Koji Maemura: Innovator in Medical Diagnostics
Introduction
Koji Maemura is a distinguished inventor based in Bunkyo-ku, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the early detection of vasculopathy, a condition that can lead to serious health issues such as myocardial infarction and angiopathic dementia.
Latest Patents
Maemura holds a patent for a method of measuring PTX3 with high sensitivity. This innovative method provides a means to determine the severity of mild vasculopathy by measuring the PTX3 level in an assay sample using an anti-PTX3 monoclonal antibody. This advancement is crucial for early-stage diagnosis and intervention.
Career Highlights
Throughout his career, Koji Maemura has worked with prestigious institutions, including The University of Tokyo and Perseus Proteomics Inc. His work has been instrumental in advancing the understanding and detection of vascular-related health risks.
Collaborations
Maemura has collaborated with notable colleagues such as Tatsuhiko Kodama and Takao Hamakubo. Their combined expertise has contributed to the development of innovative diagnostic methods.
Conclusion
Koji Maemura's contributions to medical diagnostics through his patented methods highlight the importance of early detection in preventing severe health conditions. His work continues to influence the field and improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile